Buscar
Mostrando ítems 81-90 de 15817
Is The Time Coming for Plant-Made Vaccines?
(SciTechnol, 2012-10)
An editorial about the state-of-the-art of R&D for vaccines produced in plant platforms and the future expectations.
Adjuvants and delivery systems for antifungal vaccines: Current state and future developments
(Oxford Univ Press, 2015-01-01)
Mycoses are gaining increasing attention in modern medicine because of the increase in diseases associated with opportunistic fungal infections. Despite the recognized role of the immune system in the control of fungal ...
Sociodemographic Predictors Associated with the Willingness to Get Vaccinated against COVID-19 in Peru: A Cross-Sectional Survey
(MDPICH, 2021-12-30)
During the race for the development of a vaccine against COVID-19, even before itscommercialization, part of the population has already shown a growing fear of its application. Wedesigned an analytical cross-sectional ...
Sociodemographic Predictors Associated with the Willingness to Get Vaccinated against COVID-19 in Peru: A Cross-Sectional Survey
(MDPI, 2021-12-30)
During the race for the development of a vaccine against COVID-19, even before itscommercialization, part of the population has already shown a growing fear of its application. Wedesigned an analytical cross-sectional ...
Immunotherapy against murine experimental visceral leishmaniasis with the FML-vaccine
(Elsevier B.V., 2003-12-01)
The fucose mannose ligand (Leishmania donovani FML)-saponin vaccine has earlier shown its immunoprophylactic potential against visceral leishmaniasis in the CB hamster (87.7% of parasite load reduction), Balb/c (84.4%) and ...
Immunotherapy against murine experimental visceral leishmaniasis with the FML-vaccine
(Elsevier B.V., 2003-12-01)
The fucose mannose ligand (Leishmania donovani FML)-saponin vaccine has earlier shown its immunoprophylactic potential against visceral leishmaniasis in the CB hamster (87.7% of parasite load reduction), Balb/c (84.4%) and ...
Leishmune (R) vaccine blocks the transmission of canine visceral leishmaniasis - Absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs
(Elsevier B.V., 2005-09-23)
Leishmune (R) vaccine is the first licensed vaccine against canine visceral leishmaniasis. It contains the Fucose-Mannose-ligand (FML) antigen of Leishmania donovani. The potential Leishmune (R) vaccine effect on the ...
Leishmune (R) vaccine blocks the transmission of canine visceral leishmaniasis - Absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs
(Elsevier B.V., 2005-09-23)
Leishmune (R) vaccine is the first licensed vaccine against canine visceral leishmaniasis. It contains the Fucose-Mannose-ligand (FML) antigen of Leishmania donovani. The potential Leishmune (R) vaccine effect on the ...
Timeline: Vaccines
Time line vaccines
Development of a Recombinant Newcastle Disease Virus Vaccine and its Efficacy in a Broiler Farm
(2012-11-22)
Development of a Recombinant Newcastle Disease Virus Vaccine and its Efficacy in a Broiler Farm